Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT01934361 · COMPLETED
Trial details
- NCT number
- NCT01934361
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-28
- Primary completion
- 2016-07-07
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.